BioNexus Gene Lab Corp through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of 11 different diseases.

BGLC

NASDAQ:BGLC

BioNexus Gene Lab Corporation

Last Close

0.36

08/11 21:00

Market Cap

6.30M

Beta: 0.77

Volume Today

62.08K

Avg: 1.12K

PE Ratio

−1.62

PFCF: −10.84

locale

market

website

Earnings

Earnings per Share (Estimate*)

Revenue (Estimate*)

Metrics